Trials / Completed
CompletedNCT00474617
Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
A Multicenter, Parallel Group, Comparative, Phase IIIa Trial to Compare the Efficacy, Safety, and Pharmacokinetics of Org 25969 in Elderly Subjects With Adult Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the effectiveness, safety and pharmacokinetics of sugammadex in participants 65 and over with participants under 65. There is no hypothesis defined for the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | |
| DRUG | Rocurium | intravenous (IV) single bolus dose of 0.6 mg.kg-1 |
Timeline
- Start date
- 2005-12-29
- Primary completion
- 2006-10-20
- Completion
- 2006-10-20
- First posted
- 2007-05-17
- Last updated
- 2019-04-02
- Results posted
- 2019-03-25
Source: ClinicalTrials.gov record NCT00474617. Inclusion in this directory is not an endorsement.